HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 29.00
Day range
kr 28.42 - kr 29.00
Year range
kr 20.14 - kr 58.10
Market cap
1.52B SEK
Avg Volume
155.66K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Investor's Business Daily
2 hours ago
Stocks Skid Into Fed; Amazon Rises Late As AMD, Super Micro Dive
3.54%
1.14%
3.29%
1.49%
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Revenue | 55.98M | 131.38% |
Operating expense | 197.21M | 0.16% |
Net income | -218.58M | -6.41% |
Net profit margin | -390.45 | 54.01% |
Earnings per share | -4.15 | -5.87% |
EBITDA | -158.68M | 12.69% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 541.46M | -57.92% |
Total assets | 830.55M | -44.62% |
Total liabilities | 1.20B | 11.04% |
Total equity | -374.21M | — |
Shares outstanding | 52.67M | — |
Price to book | -4.08 | — |
Return on assets | -43.11% | — |
Return on capital | -62.66% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2024info | Y/Y change |
|---|---|---|
Net income | -218.58M | -6.41% |
Cash from operations | -189.14M | 8.61% |
Cash from investing | -116.00K | 78.28% |
Cash from financing | -1.86M | -5.15% |
Net change in cash | -190.60M | 8.96% |
Free cash flow | -183.64M | -35.72% |
About
Founded
2007
Website
Employees
166
